Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos M Villalón

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Pharmacology & Therapeutics|July 27, 2010
The relevance of preclinical research models for the development of antimigraine drugs: focus on 5-HT(1B/1D) and CGRP receptorsSaurabh Gupta, Carlos M Villalón
Springerplus|March 2, 2013
Headache after exposure to 'date-rape' drugsRichard Peatfield, Carlos M Villalón
Steroids|November 21, 2002
The vasodepressor effect of androgens in pithed rats: potential role of calcium channelsMercedes Perusquía, Carlos M Villalón
Pharmacology & Therapeutics|October 3, 2009
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugsCarlos M Villalón, Jes Olesen
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 19, 2007
Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implicationsCarlos M Villalón, David Centurión
Trends in Pharmacological Sciences|December 17, 2008
5-hydroxytryptamine and cardiovascular regulationAndrew G Ramage, Carlos M Villalón
Mini Reviews in Medicinal Chemistry|July 29, 2016
The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel TreatmentsCarlos M Villalón, Antoinette Maassen VanDenBrink
Expert Opinion on Drug Metabolism & Toxicology|September 25, 2024
The influence of pharmacodynamics and pharmacokinetics on the antimigraine efficacy and safety of novel anti-CGRPergic pharmacotherapies: a narrative reviewAbimael González-Hernández, Carlos M Villalón
Pharmacology & Therapeutics|September 4, 2012
Basic mechanisms of migraine and its acute treatmentLars Edvinsson, Carlos M Villalón, Antoinette MaassenVanDenBrink
Neuropharmacology|July 23, 2008
Crosstalk of vascular 5-HT1 receptors with other receptors: clinical implicationsAntoinette MaassenVanDenBrink, David Centurión, Carlos M Villalón
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Pharmacology & Therapeutics|July 27, 2010
The relevance of preclinical research models for the development of antimigraine drugs: focus on 5-HT(1B/1D) and CGRP receptorsSaurabh Gupta, Carlos M Villalón
Springerplus|March 2, 2013
Headache after exposure to 'date-rape' drugsRichard Peatfield, Carlos M Villalón
Steroids|November 21, 2002
The vasodepressor effect of androgens in pithed rats: potential role of calcium channelsMercedes Perusquía, Carlos M Villalón
Pharmacology & Therapeutics|October 3, 2009
The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugsCarlos M Villalón, Jes Olesen
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 19, 2007
Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implicationsCarlos M Villalón, David Centurión
Trends in Pharmacological Sciences|December 17, 2008
5-hydroxytryptamine and cardiovascular regulationAndrew G Ramage, Carlos M Villalón
Mini Reviews in Medicinal Chemistry|July 29, 2016
The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel TreatmentsCarlos M Villalón, Antoinette Maassen VanDenBrink
Expert Opinion on Drug Metabolism & Toxicology|September 25, 2024
The influence of pharmacodynamics and pharmacokinetics on the antimigraine efficacy and safety of novel anti-CGRPergic pharmacotherapies: a narrative reviewAbimael González-Hernández, Carlos M Villalón
Pharmacology & Therapeutics|September 4, 2012
Basic mechanisms of migraine and its acute treatmentLars Edvinsson, Carlos M Villalón, Antoinette MaassenVanDenBrink
Neuropharmacology|July 23, 2008
Crosstalk of vascular 5-HT1 receptors with other receptors: clinical implicationsAntoinette MaassenVanDenBrink, David Centurión, Carlos M Villalón
Pageof 13